BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25963756)

  • 1. Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, Minnesota.
    Yadav S; Singh S; Harmsen WS; Edakkanambeth Varayil J; Tremaine WJ; Loftus EV
    Mayo Clin Proc; 2015 Jun; 90(6):738-46. PubMed ID: 25963756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe.
    Lakatos PL; Lovasz BD; David G; Pandur T; Erdelyi Z; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Golovics PA; Vegh Z; Mandel M; Horvath A; Szathmari M; Kiss LS; Lakatos L
    J Crohns Colitis; 2013 Jun; 7(5):385-91. PubMed ID: 22766526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.
    Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Inflamm Bowel Dis; 2006 Aug; 12(8):669-76. PubMed ID: 16917220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cancer in patients with inflammatory bowel disease and venous thromboembolism: a nationwide cohort study.
    Sørensen GV; Erichsen R; Svaerke C; Farkas DK; Sørensen HT
    Inflamm Bowel Dis; 2012 Oct; 18(10):1859-63. PubMed ID: 22241668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
    Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
    Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
    Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.
    Poullenot F; Seksik P; Beaugerie L; Amiot A; Nachury M; Abitbol V; Stefanescu C; Reenaers C; Fumery M; Pelletier AL; Nancey S; Peyrin-Biroulet L; Bourreille A; Hébuterne X; Brixi H; Savoye G; Lourenço N; Altwegg R; Buisson A; Cazelles-Boudier C; Racine A; Vergniol J; Laharie D;
    Inflamm Bowel Dis; 2016 Jun; 22(6):1362-9. PubMed ID: 26919458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.
    Taborelli M; Sozzi M; Del Zotto S; Toffolutti F; Montico M; Zanier L; Serraino D
    PLoS One; 2020; 15(6):e0235142. PubMed ID: 32574216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
    Jess T; Horváth-Puhó E; Fallingborg J; Rasmussen HH; Jacobsen BA
    Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk in patients with inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Kliewer E; Wajda A
    Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database.
    McAuliffe ME; Lanes S; Leach T; Parikh A; Faich G; Porter J; Holick C; Esposito D; Zhao Y; Fox I
    Curr Med Res Opin; 2015; 31(9):1655-64. PubMed ID: 26135040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
    Din H; Anderson AJ; Ramos Rivers C; Proksell S; Koutroumpakis F; Salim T; Babichenko D; Tang G; Koutroubakis IE; Schwartz M; Johnston E; Barrie A; Harrison J; Hashash J; Dunn MA; Hartman DJ; Binion DG
    Inflamm Bowel Dis; 2020 Aug; 26(9):1436-1442. PubMed ID: 31944255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.